A pilot study of bovine bone for orbital implants in rabbits by Shariff, Mohd Mansor
A Pilot Study 
Of Bovine Bone for Orbital Implants in Rabbits 
By 
DR. MOHD MANSOR SHARIFF 
MD(USM) 
Dissertation Submitted In Partial Fulfilment of the 
Requirements for the Degree of Master of Medicine 
(OPHTHALMOLOGY) 
1Jb9M 
UNIVERSITI SAINS MALAYSIA 
SCHOOL OF MEDICAL SCIENCES 
UNIVERSITI SAINS MALAYSIA 
2006 
2. DISCLAIMER 
I hereby certify that the work in this dissertation is my own except for the quotations 
and summaries which have been duly acknowledged. 
Dated: 31st May 2005 
11 
Dr Mohd Mansor Shariff 
P-UM 0745 
3. ACKNOWLEDGEMENT 
(In the name of ALLAH, the Most Beneficent, and the Most Merciful) 
I would like to express my thanks to my supervisors Dr Wan Hazabbah Wan Hitam, 
Professor Dr. Abdul Rani Samsuddin and Associate Professor Dr Hasnan Jaafar for 
their constant support, assistance, guidance, comments and critism throughout the 
preparation of this dissertation. 
I would also like to forward my gratitude to Associate Professor Dr Afifi Sheikh 
Abu Bakar and his staff, the Head of Animal House Unit, for his generous 
cooperation. 
I owe special thanks to Dr Ezanee Mokhtar, Dr Salzihan and his personel especially 
Mr Zamani for performing histopathology assessment. Not to forget Mr Goh Bo 
Thong for helping me to perform the preparation of bovine bone implant. 
My very special thanks to my beloved and beautiful wife, Dr Nezrean Radzana 
Mohamed, my sons Luqman Hakim and Luqman Haiqal and my charming daughter 
Nur Fatin Sofea whose patience, encouragement and understanding have guided me 
through this dissertation. 
Finally, I would like to acknowledge the research grant provided by Universiti Sains 
Malaysia that has resulted in this dissertation. 
111 
4. TABLE OF CONTENTS 
Contents Page 
1. TITLE 
2. DISCLAIMER 11 
3. ACKNOWLEDGEMENTS 11I 
4. TABLE OF CONTENTS IV 
5. LIST OF TABLES V11I 
6. LIST OF FIGURES IX 
7. ABSTRAK Xlli 
8. ABSTRACT XV 
9. CHAPTER 1: INTRODUCTION 
1.1 Introduction 2 
1.2 Background 3 
1.3 Indications of orbital implants 4 
1.4 Surgical procedure 5 
1.5 Orbital implants 6 
1.6 Types of orbital implants 9 
1.6.1 Non integrated orbital implants 9 
1.6.2 Integrated orbital implants 10 
1.7 Hydoxyapatite orbital implants 12 
1.8 Ocular prosthesis 18 
1.9 Inflammation 22 
1.8.1 Acute Inflamtnation 23 
1.8.2 Chronic Inflammation 24 
IV 
10. CHAPTER 2: STUDY OBJECTIVES 
2.1 General objective 
2.2 Specific objectives 
11. CHAPTER 3: MATERIALS AND METHODS 
3.1 Research strategy 
3.2 Sample, setting and time 
3.3 Study design 
3.4 Ethical approval 
3.5 Sampling and sample size 
3.5.1 Sampling method 
3.5.2 Sample size 
3.6 Selection criteria 
3.6.1 Inclusion criteria 
3.6.2 Exclusion criteria 
3.7 Methods to Minimize Error 
3.8 Definition of Terms 
3.9 Procedure 
3.9.1 Selection of rabbits 
3.9.2 Orbital implants 
3.9.3 Surgical procedure 
3.10 Study materials 
3.11 Phases of Investigation 
3.11.1 Phase I: Preparation of bovine bone orbital implants. 
3.11.2 Phase 2: Evisceration with and without orbital implants 
3.11.3 Phase 3: Clinical assessment of rabbits between two groups 
v 
27 
27 
29 
29 
29 
29 
30 
30 
31 
31 
31 
32 
34 
34 
34 
35 
37 
38 
42 
3.11.4 Phase 4: Enucleation. 43 
3 .11.5 Phase 5: Gross section and histopathology examination 45 
3.12 Data collection and analysis 
12. CHAPTER4: RESULTS 
4.1 Serial Clinical Examination 
4.2 Postoperative inflammation 
4.3 Urine colour and odour 
4.4 Physical activity 
4.5 Feeding activity 
4.6 Number of implant extrusion 
4.7 Ocular motility 
4.8 Wound intergrity 
4.9 Gross and Microscopic Histopathology Examination 
4.10 Inflammatory reaction 
4.11 Fibrovascular ingrowth 
13. CHAPTER 5: DISCUSSION 
5.1 Discussion 
5.2 Limitations of Study and Recomn1endations 
5.2.1 Orbital implants 
5 .2.3 Sam pel size 
5.2.4 Histopathology examination 
14. CHAPTER 6: CONCLUSION 
15. CHAPTER 7: REFERRENCES 
16. CHAPTER 8: APPENDICES 
Appendix A: Flow chart of the study 
VI 
48 
50 
51 
52 
53 
54 
55 
56 
57 
58 
61 
62 
64 
67 
67 
68 
68 
71 
73 
78 
79 
Appendix B: Data Collection Sheet I 81 
Vll 
Table 4.1 
Table 4.2 
Table 4.3 
Table 4.4 
5. LIST OF TABLES 
Progression of postoperative ocular inflammation between two 
groups 
Progression of urine colour and odour between two groups 
Progression of physical activity between two groups 
Progression of feeding activity between two groups 
Vlll 
Page 
51 
52 
53 
54 
6. LIST OF FIGURES 
Page 
Figure 1.1 Saggital section of globe with orbital implants 15 
Figure 1.2 Saggital section eye globe with orbital implants and pegging 21 
Figure 3.1 Photograph showing the orbital implant after complete 38 
preparation 
Figure 3.2 The subject under anaesthesia and ts being prepared for the 39 
evisceration 
Figure 3.3 The surgeon performing an evisceration on rabbit 40 
Figure 3.4 The rabbit after completion of procedure without any orbital 40 
implant 
Figure 3.5 An orbital implant was placed within the sclera 41 
Figure 3.6 An orbital implant in situ within the sclera 41 
Figure 3. 7 An orbital implant within the eye 42 
Figure 3.8 Photograph of a rabbit with no obvious clinical rejection at day 7 43 
post evisceration 
Figure 3.9 Enucleation was performed on rabbits which have orbital implant 44 
Figure 3 .I 0 Enucleated rabbit eye 45 
Figure 3.11 Enucleated rabbit eye 43 
Figure 4.1 Number of implants extrusion 55 
Figure 4.2 The range of ocular motility after orbital implant 56 
Figure 4.3 The intergrity of wound which orbital implant had been 57 
implanted 
IX 
Figure 4.4 A gross specimen of the orbital soft tissue content without the 58 
implant 
Figure 4.5 A gross specimen of the orbital implant sectioned into halves 59 
Figure 4.6 The fibrovascular ingrowth towards orbital implant 60 
Figure 4.7 The rate of inflammatory reaction toward orbital implant 61 
Figure 4.8 All rabbits which implanted using bovine bone orbital implant 62 
had fibrovascular ingrowth towards the implants 
X 
7. ABSTRAK 
Objektif: 
Kajian ini adalah untuk mengenal pasti tindakbalas klinikal dan bioserasi tulang bovine 
yang telah dijadikan implan bagi mata amah. Kajian ini juga digunakan bagi mengenal 
pasti samada implan ini tidak mempunyai kesan-kesan sampingan seperti migrasi 
implan , jangkitan yang keterlaluan mahupun kegagalan bola mata bergerak secara 
normal dan akhimya bagi membuktikan bahawa implan ini mempunyai bioserasi ke atas 
amah yang menjalani pembedahan implan tersebut. Kajian ini juga dapat memastikan 
implan ini selamat dan kos efektifbila dibandingkan dengan implan yang sedia ada. 
Tatacara: 
Kajian ini dijalankan melalui eviserasi ke atas mata kanan 12 ekor amah New Zealand 
White. Kumpulan A (n = 6) dieviserasi tanpa meletakkan implan manakala kumpulan B 
(n = 6) dieviserasi dengan meletakkan implant tulang bovine. Pemeriksaan klinikal 
dijalankan pada hari pertama , ketujuh , keempat belas , kedua puluh Iapan dan hari 
keempat puluh dua. Pada hari keempat puluh dua, enuklasi dilakukan pada mata yang 
telah diletakkan implant tulang bovine. Mata tersebut dihantar ke makmal untuk 
dikulturkan dan pemeriksaan patologi. Ini bertujuan untuk memastikan tindakbalas 
bioserasi implan ke atas mata amah 
Xl 
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Keputusan: 
Ciri-ciri klinikal yang dikaji dari hari pertama hingga hari keempat puluh dua dan 
akhimya tindakbalas bioserasi dijalankan di makmal patologi. Keputusan yang telah di 
dapati menunjukkan tiada tindakbalas klinikal yang ketara meskipun terdapat ciri-ciri 
jangkitan pada hari pertama tetapi ia menunjukkan respon yang sempuma pada hari 
yang berikutnya. Komplikasi seperti migrasi implan , luka terkena jangkitan mahupun 
luka yang terbuka dan bola mata tidak dapat bergerak secara sempuma tidak dapat 
dijumpai ketika kajian dijalankan . Hasil pemeriksaan histopatologi menunjukkan 
berlakunya biokeserasian di antara implan kepala tulang femur lembu dengan mata 
kanan amah seperti mana yang telah ditunjukkan di dalam ciri-ciri klinikal yang lain 
seperti yang telah dibuktikan sebelum ini. 
Kesimpulan: 
Andaian yang dapat dibuat daripada basil kajian ini mendapati tulang bovine adalah 
efektif dan kurang kesan sampingan bagi digunakan keatas amah mahupun 
kemungkinan besar bagi manusia. Ia agak selamat berdasarkan kurangnya kesan 
sampingan dan implan ini berjaya menunjukkan ia sebati dengan penerima implan iaitu 
amab. Implan ini juga amat selamat dan kos efektif berbanding dengan implan yang 
sedia ada. 
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8. ABSTRACT 
Objective: 
To assess the biocompatibility of bovine bone xenograft as ocular implants in rabbits. 
At the same time, to determine the presence of histopathological and clinical rejection 
towards bovine bone xenograft as ocular implant in rabbits. 
Methodology: 
Eviscerations with and without bovine bone orbital implantation were performed onto 
the right eye of 12 New Zealand white rabbits. Group A (n = 6) was eviscerated without 
implant whereas Group B (n = 6) was eviscerated with insertion of an orbital implant 
using bovine bone. Observation was done at day 1, day 7, day 14, day 28 and day 42. 
Serial clinical examination was done based on a few fixed criteria including rate of 
infection, implant migration, any evidence of wound breakdown and any restriction of 
intraocular movements. The implanted eyes were then enucleated on day 42. The 
enucleated eyes were sent for histopathological evaluation to record the type of 
inflammatory reaction and rate of fibrovascular ingrowth. 
Results: 
Serial clinical examination showed presence of minimal infection in all eyes both in the 
control group and the implanted first post operative day, which responded well with 
antibiotics. Infection occured after first post operative day but there was no evidence of 
orbital migration or extrusion of implant, wound breakdown, restriction of extra ocular 
Xlll 
movement, severe infection or any physical abnormality of implanted groups. 
Histopathological examination revealed good fibrovascular ingrowth in implanted 
groups, with minimal reaction of rabbit eye towards bovine bone implant. 
Conclusion: 
Orbital bovine bone implants was highly biocompatible with minimal infection during 
the early period and no evidence of clinical rejection. Histopathology examination 
supported the evidence of good fibrovascular ingrowth and minimal inflammatory 
reaction towards the implants. We can thus conclude that this bovine bone implant has a 
high potential for use clinically with the added advantage of being cost effective. 
XlV 
Chapter 1 
Introduction 
1.1 Introduction 
The search for the ideal ocular implant for the anopthalmic socket continues to evolve. 
This ocular implant must be able to compensate the orbital volume deficits in the absence 
of the globe. It must be biocompatible and should have minimal rates of migration, 
extrusion, exposure and infection. Finally, the ocular implant should be able to 
accommodate ocular motility as much as possible reproducing the normal movement of 
the eyeball. 
Many materials and implants types have been used to fulfil the above objectives. 
Currently synthethic porous ocular implants such as hydroxyappatite and porous 
polyethylene have yielded excellent motility and cosmesis with minimal complications. 
However these materials are expensive. 
To our knowledge the use of bone grafts as ocular implants have not been conducted 
either animal or human clinical studies. However, of late bone allograft have been used 
for the management of orbital floor fractures reconstruction (AR Samsudin , 1995 ). This 
result showed that the allograft was well tolerated without failures. The cost of the 
allograft locally was RM 12.00 for the size of 2 em x 2 em x 1 em and this makes it very 
cost effective. 
In this pilot study, a bone graft will be experimentally used as an ocular implant in 
rabbits to determine whether it could be successfully used in the anopthalmic socket as 
an alternative to the expensive synthetic alloplastics. 
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1.2 Background 
Artificial eyes can be dated back to approximately 2500 BC, during the Egyptian Fourth 
through Sixth Dynasty. The artificial eyes were used in the mummification process and 
were made of gold, silver, marble and other luxurious materials. There is also evidence 
that artificial eyes were present in Ancient Rome, Greece and China. In the mid 1500's 
Ambrose Pare a French military surgeon, the first to document the use of artificial eyes in 
human by using first made eyes from glasses (Alexander, 1996). During World War II, 
other materials have been experimentally used such as gold, silver and porcelain. 
In 1944, a dentist W.D. Barker created an acrylic eye to be used for orbital implant. His 
theories stated that this new material was more resistant to scratches; breakage and attack 
by lacrimal secretions were proved to be true. W.D. Barker continued to develop his ideas 
and soon was able to produce large quantities of eyes by making half spherical eyes 
pressed in molds and hand painted. 
In 1874, Noyes performed routine evisceration in cases of severe infection. His method 
involved incising the cornea to remove the contents of the globe and claimed that he 
was able to obtained good cosmetic results and had no cases of sympathetic ophthalmia. 
In 1884, Mules was the first to introduce a hollow glass ball into the scleral cavity after 
the removal of the cornea. 
Later these procedures become unpopular because of the fear of sympathetic ophthalmia 
and reports of shattering of the glass ball. During World Wars I and II a tremendous 
calamities of facial injuries then generate the interest of many surgeon to renewed the 
evisceration procedures allowing the best cosmetic outcomes. 
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1.3 Indication of Orbital Implants 
Losing an eye to trauma, tumor or end stage ocular disease such as glaucoma can be 
devastating at any age. It may have a major impact on ones self-image, self-confidence 
and self-esteem not to mention the adjustment required in adapting to monocular vision. 
Furthermore there are several job restrictions that apply for one-eyed patients. Thus it is 
important for the artificial eye patient to maintain a natural, less interaction and normal 
appearing prosthetic eye. 
Before making the decision to remove an eye, consideration should be given to all 
alternatives and make every attempt to preserve eyes that have potential for useful vision. 
In the vast majority patients who had their eye removed, the damaged or diseased eye has 
little or no vision remaining. 
There are several indications that could warrant removal of an eye, including: 
1. A painful blind eye. 
2. A severely traumatized eye. 
3. Life threatening tumors such as malignant melanoma. 
4. Poor cosmetic appearance of blind eye. 
5. Presence or risk of symphathetic opthalmitis. 
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1.4 Surgical Procedure 
There are two methods available, namely evisceration and enucleation, to remove the 
eye to provide pain relief and prepare for reconstruction of the anophthalmic socket. 
Each has their own benefits, and the decision as to which procedure is a best need to be 
customized. 
During evisceration, the contents of the eye are removed, leaving behind a pocket of 
sclera. The pouch of sclera is filled with an orbital implant or sphere. The sphere may be 
made of polymethylmethaarylate (PMMA) or hydroxyapatite material. This orbital 
sphere or implant remains permanently behind the soft tissues of the orbit, Tenon's and 
conjunctiva (Hersh, 1988). The tissues are allowed to heal for 6-8 weeks prior to the 
fitting of the ocular prosthesis. Because muscles that control eye movement remain 
attached to the sclera, and as a result evisceration generally gives better movement to 
the ocular prosthesis (artificial eye) than most types of enucleation procedures. 
Evisceration involves complete removal of the ocular contents through an opening in 
the cornea or sclera, leaving the optic nerve and sclera along with attached extraocular 
muscles. The first evisceration was recorded in 1817 when an iridectomy for acute 
glaucoma was complicated by an expulsive haemorrhage forcing James Bear, an 
ophthalmic surgeon to remove the contents of the globe. 
Evisceration was considered in cases such as endopthalmitis unresponsive to antibiotics 
and improvement of cosmesis in a blind eye but it is contraindicated in cases of 
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suspected intraocular malignancy and may not relieve the pain associated with blind eye 
since ciliary nerves remain intact. 
Enucleation involves the removal of the entire globe with preservation of the eye 
muscles (Hersh, 1988). These muscles can be placed around an orbital implant to 
facilitate movement of the prosthetic eye. Under certain rare conditions e.g in cases of 
extensive orbital malignancy and severe infection, an implant cannot be used. 
There are advantages and disadvantages of evisceration comparing to enucleation. An 
advantage of evisceration gives a better cosmetic result with good superior motility of the 
prosthesis (Bailey, 1988). There are fewer tendencies toward the development of 
enopthalmos and deep supratarsal sulcus formation. Also orbital volume can be 
maintained close to the original state and in cases of endopthalmitis, evisceration avoids 
further contamination of the orbit and spreads of infection into subarachnoid space. 
1.5 Orbital Implants 
In managing anopthalmic socket, two major components are important; an orbital implant 
to maintain the volume of the eye socket and an artificial eye or prosthesis. A variety of 
materials have been used for the orbital implant including gold, silver, cartilage, bone, fat, 
cork, titanium mesh, acrylics and silicone in an attempt to find the most biocompatible, 
least reactive implant over the last 100 years. A variety of shapes and sizes have also 
been tried to try and provide some motility to the socket. 
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The first-generation implants were a major improvement for those wearing an artificial 
eye, but they were unable to deliver a natural movement to the artificial eye. This lack 
of movement was a major obstacle to restoring a natural appearance, which made the 
adjustment to wearing an artificial eye much more difficult. 
The first-generation implants also tend to drift (migrate) in the orbit and were often 
rejected by the body, making further surgery necessary. These problems inspired 
researchers to seek a better orbital implant. 
When an eye is removed, an orbital implant is used to replace the volume in the orbit 
(bony cavity surrounding the eye) that was previously occupied by the eye. This small, 
spherical implant maintains the natural structure of the orbit and provides support for 
the artificial eye without being visible. 
While artificial eyes have been made for thousands of years, the first orbital implant was 
developed only about 100 years ago. These small spheres of glass or gold were later 
replaced by plastic or silicone spheres. The basic design of these first-generation orbital 
implants changed little and minimally over the years until the development of the Bio-eye 
Orbital Implant in 1985. 
The first step in the quest for an ideal implant, however, began with a focus on the less 
significant but more manageable problem of reducing the complications common to 
existing synthetic implants. The basic strategy was to develop an orbital implant that 
incorporated all of the design features that the literature review had shown to be common 
features of the most successful implant designs. 
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The ideal features of orbital implants should include the following factors; 
a. Maintain natural lid shape 
• The implant must provide a means, such as the ability to receive a 
motility/support peg, to support the weight of the artificial eye to prevent 
damage to the delicate muscles of the lower lids over time. 
b. Light weight 
• The implant must be light in weight. 
c. Porosity 
• The implant must allow vascular orbital tissues to invade its structure to: 
a. Lock it into place and prevent migration, 
b. Allow it to overcome infections from within the implant vta the 
vascular bed infiltrating the implant 
c. Support "healing from within" of any defect tn the conjunctival-
Tenon's closure. 
d. True integration 
• The implant must be directly integrated (e.g., via a peg) with the artificial eye 
to allow direct transfer of all available movement from the rectus muscles to 
the artificial eye. 
e. Natural biocompatibility 
• The implant must be a natural material and readily accepted by the tissues of 
the orbit to prevent "synthetic implant syndrome" i.e., pseudocapsule 
formation around the implant. This pseudocapsule is the body's way of 
walling off a foreign material. Presence of this pseudocapsule will cause 
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rejection of implants and not allowing fibrovasular ingrowth towards the 
implant. 
1.6 Types of Orbital Implants 
Orbital implants replace the volume lost by the eviscerated or enucleated eye. There are 
two major groups of orbital implants. 
1. Integrated. 
2. Non integrated. 
1.6.1 Non Integrated Orbital Implants 
Non integrated implants contain no unique apparatus for attachments to the extraocular 
muscles and do not allow ingrowth of organic tissue into their organic substance. These 
types of implants have no direct attachment to the ocular prosthesis. 
Materials used as non-integrated implants include glass, rubber, silicone, steel, gold, 
silver, acrylic and polymethylmethacrylate (PMMA). As compared without any implants, 
these materials provide both volume replacement and improved cosmesis. 
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1.6.2 Integrated Orbital Implants 
A. Hydroxyapatite 
This type of orbital implant is commonly used during enucleation surgery. It is 
formed from a salt of calcium phosphate that is present in the mineralized portion of 
human bone. It is reported to be non-toxic, nonallergenic, and biocompatible. Its 
porous structure allows integration of fibrovascular tissues into the stroma of the 
implant. 
Sires and associates postulate the pore orientation in the hydoxyappatite sphere may 
influence the degree of vascularization and that poor vascularization might result in 
implant extrusion. 
Fibrovascular ingrowth and density changes have been assessed by a variety of 
radiographic techniques but contrast-enhanced magnetic resonance imaging with 
surface coil appears to be the modality of choice. 
These radiograpichs techniques have been demonstrated by Jamell and coworkers 
how magnetic resonance imaging with contrast enhancement shows early peripheral 
vascularization of the implant, with vascularization of the central core. 
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B. Porous Polyethylene 
Porous polyethylene is another integrated implant material. This spherical implant 
was approved for clinical use in reconstructive surgery in 1985. Like hydroxyapatite, 
porous polyethylene allows fibrovascular ingrowth although not as quick as 
hydroxyapatite. 
Histopathological evaluation revealed that the fibrovascular ingrowth extended to the 
central core of the implant. Advantages of the porous polyethylene device are that it 
does not require donor sclera or other type of wrapping material. 
Porous polyethylene implants are smooth and malleable, which makes implantation 
easier. The device can be implanted in the standard fashion followed by attachment of 
the extraocluar muscles at points approximating the spiral of Tillaux. One major 
disadvantages of this material was the lack of an integrating device for the ocular 
prosthesis 
C. Synthetic Hydroxyapatite 
Synthetic hydroxyapatite has been noted to maintain all of the functional 
characteristics of traditional hydroxyapatite, but at half the cost. Jordan et al reported 
on 60 patients who had this implants, there was only one wound dehiscence and 
minor problems common to traditional hydroxyapatite implants. Synthetic 
hydroxyapatite implants appear to be a cost effective alternative to traditional 
hydroxyapatite implants. 
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D. Proplast 
Proplast is an inert, porous, alloplastic material originally used in orthopaedic 
procedures. It allows fibrovascular ingrowth and attachment of extraocular muscles 
and has been used as a subperiosteal implant and an orbital implant. 
Neuhaus et al noted that there were no cases of implant migration or extrusion during 
2 years in the first four patients and 1 year in an additional six patients. 
E. Other Implants 
Many substances have been considered for use tn orbital implants. 
Polytetrafluoroethylene that was previously investigated for use as wrapping material 
for hydroxyapatite implants has recently been investigated for use in spherical orbital 
implants in a rabbit model. 
1.7 Hydroxyapatite Orbital Implants 
The first orbital implant made of hydroxyapatite was implanted in 1985, by Dr. Arthur 
Perry, after several years of preliminary research but hydroxyapatite was first used in 
animal studies as an ocular implant in 1983 (Ashworth J.L, 1996). In August 1989, the 
FDA released the first HA ocular implant, now known as the Bio-eye HA ocular implant. 
These spheres are completely porous throughout their structure and have an average pore 
size of0.5 mm. Natural porous HA is very much like human cancellous bone. 
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The advantages of using natural porous hydroxyapatite as an ocular implant include: 
1. Decreased lower -lid sag due to the peg's support of the weight of the 
artificial eye. 
2. Potential for direct coupling with the artificial eye to make the artificial 
eyes move in conjunction with normal eye. 
3. Decreased migration. 
4. Decreased extrusion. 
5. Resistance to infection. 
Hydroxyapatite , the major chemical component of bone , has the chemical composition 
Ca10{P04)6(0H)2 • Hydroxyapatite is an inert, biocompatible, non-toxic and non-allergenic 
bio ceramic, making it an ideal choice for an ocular implant. The hydroxyapatite 
intergrated implant to be used in this procedure is composed of calcium phosphate 
obtained from a femoral head of bovine bone. At the core of this implant, there are 
interconnecting pores about 500 Jlm in diameter (Ashworth J.L, 1996). These 
interconnecting pores allow for vascular tissue in-growth and anchorage to ocular socket. 
The hydroxyapatite implant provides for natural motility, has a lower extrusion rate than 
other eye prosthetic materials and resulting in lower risk of infection. Few sides' effects 
of this hydroxyapatite have been reported including conjunctival thinning implant 
exposure and socket infection. 
The natural hydroxyapatite orbital implant achieved its success because it is highly 
biocompatible and completely porous. Hydroxyapatite is a complex calcium phosphate, 
which is the same mineral that comprises the hard portion (mineral portion) of human 
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bone, and is therefore readily accepted by the tissues of the orbit. Additionally, natural 
hydroxyapatite is derived from a specific genus of marine coral whose exoskeleton is 
completely porous: each pore connects with every other pore (Ashworth J.L, 1996). 
This is an extremely important characteristic for long-term success. Synthetic orbital 
implants silicon; polyethylene, porous polyethylene (like Medpor) and aluminum oxide 
(like Bioceramics) have been unable to duplicate the complete interconnective 
characteristic of natural hydroxyapatite. Natural HA also matches the 500-J..Lm pore size 
characteristic of human cancellous bone (Piecuch, 1982) in which, by volume, is 50% 
hard tissue and 50% soft tissue. When placed into the orbit, natural HA becomes fully 
incorporated with the fibrovascular tissues of the orbit, and when attached to the rectus 
muscles, can deliver all available socket motility directly to the artificial eye. 
Additionally, the natural hydroxyapatite orbital implant has the longest successful track 
record of any known implant material that can successfully accommodate a 
motility/support peg, which directly connects the artificial eye to the implant. The 
complete interconnected porosity filled with fibrovascular ingrowth makes this possible. 
The motility and support peg, supports the weight of the prosthesis while 
simultaneously ensuring transfer of any socket movement directly to the prosthesis. 
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Figure 1.1 showed saggital section of globe with orbital implants 
Some years earlier, it had been discovered that certain species of marine coral have a 
skeleton with microarchitecture almost identical to that of human cancellous bone. 
Fortunately, these species also have a chemical makeup that allows them to be 
converted to hydroxyapatite (HA), which is the mineral that makes up the hard portion 
of bone. 
This remarkable coincidence enables converted coral implants to be invisible to the 
immune system, preventing the implant from producing a foreign body reaction that has 
been a complication of implants for over 100 years. Both X-ray diffraction and SEM 
microscopy have shown naturally derived HA to be virtually identical to the mineral 
portion of cancellous bone in terms of both porosity and chemical make-up. 
Consequently, soft tissue readily infiltrate the material, muscles can be attached to it 
' 
and, if exposed, the material tends to "heal" itself using the body's natural mechanisms 
for wound closure and infection resistance (Ashworth J.L, 1996). 
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The goal of a more natural appearance was finally achieved with the help of a natural 
material: ocean coral. A remarkable similarity was noticed between the porous structure 
of certain coral species and that of human bone. Soon after this discovery, a method was 
developed to transform the mineral in coral to match that of human bone, known as 
hydroxyapatite. 
This naturally derived material has both the porous structure and the chemical structure 
ofbone. Thus, the tissues of the body will accept, even grow into these naturally derived 
hydroxyapatite implants, and they essentially become a "living" part of the body. This is 
in contrast to artificially made hydroxyapatite, or the porous materials like porous 
polyethylene (Medpor) or aluminum oxide (Bioceramic) that do not have these 
properties. 
The benefits of natural movement and fewer long-term problems have made the 
hydroxyapatite orbital implant the implant of choice among leading ophthalmic and 
oculoplastic surgeons worldwide. It is the most widely used orbital implant that 
becomes a living part of the body. 
Chronic infection of hydroxyapatite implants can occur late, in the absence of large 
conjunctival defects, or other obvious risk factors. While exposure of the implant to 
pathogens through a breach in the conjunctiva may have been a factor, it appeared that 
the infection may have arisen in an avascular portion of the implant prior to the 
conjunctival breakdown in one or more of these cases. 
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The hydroxyapatite orbital implant is surgically placed within the orbit at the time the 
eye is removed, and the tissues are closed over the implant. The implant will not be 
seen. A temporary conformer (a clear plastic spacer) is then placed on top of the tissues 
covering the implant and under the eyelids to maintain the space for the future artificial 
eye. 
Fibrovascular tissue ingrowth from adjacent orbital tissue into spherical porous 
polyethylene orbital implants is well established and has been demonstrated using 
several techniques (histopathologic findings, technetium isotope scanning, computed 
tomography, and magnetic resonance imaging). Vascularization usually occurs from the 
periphery of the implant toward the center of the sphere and aids integration of the 
implant into host tissues. This is believed to reduce infection, extrusion, and exposure of 
the implant. 
Today, over 80,000 people worldwide have benefited from the Bio-eye orbital implant, 
the natural orbital implant, which is known as the Bio-eye Hydroxyapatite Orbital 
Implant. In addition to natural eye movement, the Bio-eye orbital implant offers many 
less-obvious benefits. It reduces implant migration and extrusion, which are common 
with the other implants. 
There are also porous implants of porous polyethylene, (Medpor), and of aluminum 
oxide, (Bioceramic). These are not natural materials of the body and do not have the 
same, completely porous, micro architecture as human bone or as the hydroxyapatite 
orbital implant. 
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Porous polyethylene orbital implants are increasingly popular and used commonly as 
sheets, blocks, or spheres for volume replacement in the anophthalmic socket and for 
orbital wall repair in orbital wall fractures. Synthetic orbital implants are generally less 
expensive than natural coral implants and are also biocompatible and nontoxic, with 
interconnecting pores and channels. 
The Bioceramic orbital implant (aluminum oxide, Ah03, alumina) represents a new 
generation of porous orbital implant. It is structurally strong, free of contaminants and 
easy to work with. It has a more extensive uniform pore structure (with excellent pore 
interconnectivity) than either the Bio-Eye. 
The implant is coated with the body's own protein on implantation allowing it to 
become immunologically camouflaged. The US Food and Drug Administration 
approved the implant in April 2000 and by Health and Welfare Canada in February 
2001. 
1.8 Ocular Prosthesis 
An artificial eye, or ocular prosthesis, is the items that need to be esthethically pleasing 
since it is seen by other people and is used to restore the natural appearance of the eye 
and surrounding tissues. It reflects the post surgical changes to the socket (the space 
behind the eyelids in which the artificial eye rests). Artificial eyes are usually made of 
plastic, acrylic, or glass. 
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The artificial eye shell or ocular prosthesis is composed of methyl methacrylate (MMA). 
MMA is a plastic that is molded to fit between patient's eyelids and over the 
hydroxyapatite implant. The natural features of the eye such as the iris, blood vessels and 
any tints or shading in the sclera are painted onto the shell. The MMA is transparent; zinc 
oxide is added to produce the white background of the sclera. 
Besides providing cosmetic benefits, the artificial eye supports the eyelids, preventing 
drooping and allowing for normal opening and closing of the eyelids. The artificial eye 
shell also prevents the eyelashes from turning in and provides proper lubrication of the 
eye tissues. 
Confusion often exists in terminology with respect to orbital implant and ocular 
prosthesis. An ocular or orbital implant is placed in the deep tissues of the bony socket 
and is permanent. An ocular prosthesis (artificial eye) is like a giant contact lens, on 
which an eye is carefully painted to match the remaining good eye. The prosthesis can 
be removed and polished on a regular basis. Approximately six weeks after either 
enucleation or evisceration, an ocularist will make an impression of the patient's socket 
to create an ocular prosthesis or artificial eye. The ocularist will make prosthesis with 
eye color and shape to match the remaining eye. 
Then the oculoplastics surgeon will create a detailed artificial eye; often astonishing in 
its lifelike appearance that exactly matches your natural eye. The artificial eye fits over 
the tissues that cover the implant and under the eyelids, and will move as the implant 
moves or "tracks" along with the natural eye. 
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Desired movement is achieved, can perform a simple procedure to connect the artificial 
eye to the implant, by means of a peg. In this optional procedure, a hole is placed in the 
implant and a peg is inserted into the hole. Titanium is now the material of choice used 
for the pegging system. 
Once the peg is placed in the implant, a month of healing is suggested before the 
ocularist modifies the back of the artificial eye to accept the head of the peg, thus 
forming a direct link to the artificial eye. The artificial eye can be worn as usual during 
the period. 
The peg placement procedure can only be performed after the implant has had time to 
fill with vascular tissues from the orbit, usually about six months after implantation. A 
bone scan or magnetic resonance imaging (MRI) test should be performed to confirm 
whether the implant has had adequate vascular ingrowth and is ready to accept a peg. 
These tests, as well as the peg placement procedure, are usually painless. 
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Titanium peg 1 
Figure 1.2 showed saggital section eye globe with orbital implants and pegging 
Pegging will allow coupling of the Bioceramic implant to the overlying prosthetic eye 
and as a result, an increased range of movement as well as simultaneous movement of 
the artificial eye with the normal eye. The small dart-like tracking movements that occur 
give the artificial eye a more life-like appearance. Although pegging increases the 
movement, potential problems (most of which are minor) can occur in up to 1/3 of 
patients. To peg or not to peg is up to the surgeon and patient. 
The most common type of peg system used at this time involves a Titanium peg and 
sleeve system. Earlier models of the peg and sleeve were polycarbonate; however 
titanium has proven to be more bioinert. This coating allows fibroblasts to gain a 
stronger attachment to the sleeve as compared to uncoated titanium (i.e. retention 
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strength is improved). A Bioceramic sleeve (made of the same aluminum oxide material 
as the implant) in association with a titanium peg will also be available shortly. Either 
system works well and replaces the older polycarbonate or polymethylmethacrylate peg 
systems. 
Approximatelly, six weeks after surgery, an ocular prosthesis is placed in front of the 
orbital implant. Then six months after the initial surgery, a bone scan or gadolinium 
enhanced MRI is performed to document healing. When healing is complete, a small 
hole is drilled into the hydroxyapatite implant and a peg with or withoiut a sleeve is 
inserted. The back of the ocular prosthesis can engage this peg, imparting almost normal 
motility through a ball and socket joint. 
1.9 Inflammation 
Inflammation is fundamentally a protective response that is to rid the organism from 
initial cause of cell injury and the consequences of such injury. Without inflammation, 
infections would go unchecked, wound would never heal and injured organs might 
remain permanent festering sores. 
Fibrosis may lead to disfiguring scars and fibrous bands that cause limits the mobility of 
joints. The inflammatory response occurs in the vascularized connective tissue, 
including plasma, circulating cells, blood vessel and cellular or extracellular 
constituents of connective tissue. 
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The circulating cells include neutrophils, monocytes, eosinophils, lymphocytes, 
basophils and platelets. The connective tissue cells are the mast cells that intimately 
surround blood vessels, the connective tissue fibroblasts and occasional resident 
macrophages and lumphocytes. The extracellular matrix consists of the structural 
fibrous proteins, adhesive glycoproteins and proteoglycans. The basement membrane is 
a specialized component of the extracellular matrix consisting of adhesive glycoproteins 
and proteoglycans. 
Inflammation is divided into acute and chronic patterns. Acute inflammation is of 
relatively short duration, lasting for minutes, several hours or a few days and its main 
characteristics are the exudation of fluid and plasma proteins and the emigration of 
leukocytes predominantly neutrophils. Whereas chronic inflammation longer duration 
and associated histologically with the presence of lymphocytes and macrophages, the 
prolifearation of blood vessels, fibrosis and tissue necrosis. 
1.9.1 Acute Inflammation 
Acute inflammation is the immediate and early response to an injurious agent. Acute 
inflammation has three major components; 
a. Alterations in vascular calibre that lead to an increase in blood flow. 
b. Structural changes in the microvasculatures that permit the plasma 
proteins and leukocytes to leave the circulation. 
c. Emigration of the leukocytes from the microcirculation and their 
accumulation in the focus of injury. 
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Exudates are an inflammatory extravascular fluid that has a high protein concentration 
much cellular debris and a specific gravity above 1.012. Transudate is a fluid with low 
protein content and a specific gravity of less than 1.0 12. It is essentially an ultrafiltrate 
of blood plasma and results from hydrostatic imbalance across the vascular 
endothelium. 
1.9.2 Chronic Inflammation 
Chronic inflammation is considered inflammation of prolonged duration (weeks or 
months) in which active inflammation; tissue destruction and attempts at repair are 
proceeding simultaneously. Although it may follow acute inflammation, chronic 
inflammation frequently begins insidiously as a low grade, smoldering, and often-
asymptomatic response. 
Chronic inflammation arises under the following settings: 
a. Persistent infections by certains microorganisms. 
b. Prolonged exposure to potentially toxic agents either exogenous or 
endogenous. 
c. Autoimmunity which is tmmune reaction is set up against the 
individual's own tissues. 
Histological features of chronic inflammation are characterized by: 
a. Infiltration with mononuclear cells that include macrophages, 
lymphocytes and plasma cells - a reflection of a persistent reaction to 
InJUry. 
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